Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Mu and delta opioid receptors play opposite nociceptive and behavioural roles on nerve-injured mice.

Martínez-Navarro M, Cabañero D, Wawrzczak-Bargiela A, Robe A, Gavériaux-Ruff C, Kieffer BL, Przewlocki R, Baños JE, Maldonado R.

Br J Pharmacol. 2019 Oct 26. doi: 10.1111/bph.14911. [Epub ahead of print]

PMID:
31655493
2.

Influence of behavioral traits in the inter-individual variability of nociceptive, emotional and cognitive manifestations of neuropathic pain.

Martínez-Navarro M, Lara-Mayorga IM, Negrete R, Bilecki W, Wawrzczak-Bargieła A, Gonçalves L, Dickenson AH, Przewłocki R, Baños JE, Maldonado R.

Neuropharmacology. 2019 Apr;148:291-304. doi: 10.1016/j.neuropharm.2019.01.012. Epub 2019 Jan 19.

PMID:
30668942
3.

Glucocorticoid receptor signaling in astrocytes is required for aversive memory formation.

Tertil M, Skupio U, Barut J, Dubovyk V, Wawrzczak-Bargiela A, Soltys Z, Golda S, Kudla L, Wiktorowska L, Szklarczyk K, Korostynski M, Przewlocki R, Slezak M.

Transl Psychiatry. 2018 Nov 28;8(1):255. doi: 10.1038/s41398-018-0300-x.

4.

Alterations in the Activity of Spinal and Thalamic Opioid Systems in a Mice Neuropathic Pain Model.

Rojewska E, Wawrzczak-Bargiela A, Szucs E, Benyhe S, Starnowska J, Mika J, Przewlocki R, Przewlocka B.

Neuroscience. 2018 Oct 15;390:293-302. doi: 10.1016/j.neuroscience.2018.08.013. Epub 2018 Sep 1.

PMID:
30176322
5.

Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.

Górska AM, Kamińska K, Wawrzczak-Bargieła A, Costa G, Morelli M, Przewłocki R, Kreiner G, Gołembiowska K.

Neurotox Res. 2018 Apr;33(3):532-548. doi: 10.1007/s12640-017-9831-9. Epub 2017 Nov 13.

6.

Behavioral and transcriptional patterns of protracted opioid self-administration in mice.

Skupio U, Sikora M, Korostynski M, Wawrzczak-Bargiela A, Piechota M, Ficek J, Przewlocki R.

Addict Biol. 2017 Nov;22(6):1802-1816. doi: 10.1111/adb.12449. Epub 2016 Aug 31.

PMID:
27578564
7.

Opioid-dependent regulation of high and low fear responses in two inbred mouse strains.

Szklarczyk K, Korostynski M, Cieslak PE, Wawrzczak-Bargiela A, Przewlocki R.

Behav Brain Res. 2015 Oct 1;292:95-101. doi: 10.1016/j.bbr.2015.06.001. Epub 2015 Jun 5.

PMID:
26051817
8.

Behavioral and molecular alterations in mice resulting from chronic treatment with dexamethasone: relevance to depression.

Skupio U, Tertil M, Sikora M, Golda S, Wawrzczak-Bargiela A, Przewlocki R.

Neuroscience. 2015 Feb 12;286:141-50. doi: 10.1016/j.neuroscience.2014.11.035. Epub 2014 Nov 27.

PMID:
25433240
9.

Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain.

Mika J, Osikowicz M, Rojewska E, Korostynski M, Wawrzczak-Bargiela A, Przewlocki R, Przewlocka B.

Eur J Pharmacol. 2009 Nov 25;623(1-3):65-72. doi: 10.1016/j.ejphar.2009.09.030. Epub 2009 Sep 17.

PMID:
19766105
10.

Regulation of kinesin light chain 1 level correlates with the development of morphine reward in the mouse brain.

Bilecki W, Wawrzczak-Bargiela A, Przewłocki R.

Eur J Neurosci. 2009 Sep;30(6):1101-10. doi: 10.1111/j.1460-9568.2009.06886.x. Epub 2009 Sep 4.

PMID:
19735294
11.

Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice.

Mika J, Wawrzczak-Bargiela A, Osikowicz M, Makuch W, Przewlocka B.

Brain Behav Immun. 2009 Jan;23(1):75-84. doi: 10.1016/j.bbi.2008.07.005. Epub 2008 Jul 22.

PMID:
18684397
12.
13.

alpha-Synuclein expression in the brain and blood during abstinence from chronic alcohol drinking in mice.

Ziolkowska B, Gieryk A, Wawrzczak-Bargiela A, Krowka T, Kaminska D, Korkosz A, Bienkowski P, Przewlocki R.

Neuropharmacology. 2008 Jun;54(8):1239-46. doi: 10.1016/j.neuropharm.2008.04.001. Epub 2008 Apr 8.

PMID:
18456291
14.

Interleukin-1 alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model.

Mika J, Korostynski M, Kaminska D, Wawrzczak-Bargiela A, Osikowicz M, Makuch W, Przewlocki R, Przewlocka B.

Pain. 2008 Sep 15;138(3):587-97. doi: 10.1016/j.pain.2008.02.015. Epub 2008 Apr 18.

PMID:
18374486
15.

Effects of glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibitors on morphine-induced analgesia and tolerance in rats.

Parkitna JR, Obara I, Wawrzczak-Bargiela A, Makuch W, Przewlocka B, Przewlocki R.

J Pharmacol Exp Ther. 2006 Nov;319(2):832-9. Epub 2006 Aug 10.

PMID:
16902054
16.

Morphine activates Arc expression in the mouse striatum and in mouse neuroblastoma Neuro2A MOR1A cells expressing mu-opioid receptors.

Ziółkowska B, Urbański MJ, Wawrzczak-Bargieła A, Bilecki W, Przewłocki R.

J Neurosci Res. 2005 Nov 15;82(4):563-70.

PMID:
16211563
17.

Regulation of the extracellular signal-regulated kinases following acute and chronic opioid treatment.

Bilecki W, Zapart G, Ligeza A, Wawrzczak-Bargiela A, Urbański MJ, Przewłocki R.

Cell Mol Life Sci. 2005 Oct;62(19-20):2369-75.

PMID:
16158186
18.

Regulation of alpha-synuclein expression in limbic and motor brain regions of morphine-treated mice.

Ziolkowska B, Gieryk A, Bilecki W, Wawrzczak-Bargiela A, Wedzony K, Chocyk A, Danielson PE, Thomas EA, Hilbush BS, Sutcliffe JG, Przewlocki R.

J Neurosci. 2005 May 18;25(20):4996-5003.

19.

Activation of AP-1 and CRE-dependent gene expression via mu-opioid receptor.

Bilecki W, Wawrzczak-Bargiela A, Przewlocki R.

J Neurochem. 2004 Aug;90(4):874-82.

Supplemental Content

Loading ...
Support Center